A network of 16 investigator sites with over 3,000 completed trials and 250 investigators
+ In the consolidating research site sector, a group of 16 established high-performing, independently-owned sites organized their Business Development efforts under a common site network brand
+ The resulting 650% increase in Sponsor/CRO study opportunities into the network drove the need for pipeline management solution configured for the unique stages and workflows of the clinical trials industry
+ Strategically, the network leadership sought to leverage real-time access to site performance metrics data as a point of differentiation in their offering to Sponsors and CROs
+ Visibility into the full study pipeline while capturing key performance metrics at each site. Quickly pulling metrics reports to aggregate for feasibility submissions and create a ‘Virtual Site Network’.
+ By mandating the use of the Devana IGNITE platform at each independent site, the network was able to provide a major global CRO with advanced performance metrics in a specific indication including: completed trials in the primary/secondary indication, total completed patients, available patients in the indication, contract met percentage and average turnaround times at crucial start-up stages and overall study start-up time
+ As the only CRO with these advanced metrics, their proposal to the Sponsor included a 6 – 8 week reduction in start-up time given the network’s demonstrated start-up proficiency and quicker trial completion based on the network’s proven patient enrollment performance
+ Based on this distinct competitive advantage, the CRO received a multi-million dollar service award and, in turn, exclusively-aligned with the site network for completing the trial